EA200700102A1 - Лечение невропатической боли, фибромиалгии или ревматоидного артрита - Google Patents
Лечение невропатической боли, фибромиалгии или ревматоидного артритаInfo
- Publication number
- EA200700102A1 EA200700102A1 EA200700102A EA200700102A EA200700102A1 EA 200700102 A1 EA200700102 A1 EA 200700102A1 EA 200700102 A EA200700102 A EA 200700102A EA 200700102 A EA200700102 A EA 200700102A EA 200700102 A1 EA200700102 A1 EA 200700102A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- fibromyalgia
- treatment
- rheumatoid arthritis
- neuropatic pain
- pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Настоящее изобретение относится к применению габоксадола для получения лекарственных средств эффективных при лечении невропатической боли, фибромиалгии или ревматоидного артрита.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/DK2004/000460 WO2006053556A1 (en) | 2004-06-29 | 2004-06-29 | Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200700102A1 true EA200700102A1 (ru) | 2007-06-29 |
Family
ID=34957949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200700102A EA200700102A1 (ru) | 2004-06-29 | 2004-06-29 | Лечение невропатической боли, фибромиалгии или ревматоидного артрита |
Country Status (13)
Country | Link |
---|---|
US (1) | US20050288371A1 (ru) |
EP (1) | EP1761263A1 (ru) |
JP (1) | JP2008504306A (ru) |
KR (1) | KR20070034070A (ru) |
CN (1) | CN1976700A (ru) |
AU (1) | AU2004324938A1 (ru) |
BR (1) | BRPI0418932A (ru) |
CA (1) | CA2572302A1 (ru) |
EA (1) | EA200700102A1 (ru) |
IL (1) | IL180250A0 (ru) |
MX (1) | MXPA06015196A (ru) |
NO (1) | NO20070440L (ru) |
WO (1) | WO2006053556A1 (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2812185B1 (fr) | 2000-07-25 | 2003-02-28 | Spine Next Sa | Piece de liaison semi-rigide pour la stabilisation du rachis |
GB0402118D0 (en) | 2004-01-30 | 2004-03-03 | Merck Sharp & Dohme | Polymorphic forms of a GABAA agonist |
WO2006083682A2 (en) | 2005-01-28 | 2006-08-10 | H.Lundbeck A/S | Polymorphic forms of a gabaa agonist |
US20070203216A1 (en) * | 2006-02-14 | 2007-08-30 | Bjarke Ebert | Method of treating inflammatory diseases |
US20070233211A1 (en) * | 2006-04-04 | 2007-10-04 | Galer Bradley S | Methods and compositions for treating non-neuropathic pain |
TW200920358A (en) * | 2007-08-13 | 2009-05-16 | Lundbeck & Co As H | Method of treating stress-mediated depression |
US20090048288A1 (en) * | 2007-08-13 | 2009-02-19 | H. Lundbeck A/S | Method of treating stress-mediated depression |
CN102552442B (zh) * | 2010-12-07 | 2014-01-01 | 北京联合大学生物化学工程学院 | 一种治疗骨质增生的中药复方滴丸及其制备方法 |
CN103520138A (zh) * | 2013-09-06 | 2014-01-22 | 潍坊锦博医药科技有限公司 | 一种治疗骨刺的新型膏药及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4276676A (en) * | 1979-07-30 | 1981-07-07 | Presto Lock Company, Division Of Walter Kidde & Company, Inc. | Handle mounting device |
US4315934A (en) * | 1979-09-24 | 1982-02-16 | Sandoz Ltd. | Organic compounds |
US4362731A (en) * | 1980-09-01 | 1982-12-07 | Sandoz Ltd. | Myotonolytic use of 4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridin-3-ol and derivatives thereof |
AR031473A1 (es) * | 2000-11-20 | 2003-09-24 | Lundbeck & Co As H | Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide |
US6835754B2 (en) * | 2001-01-08 | 2004-12-28 | Renovis, Inc. | Use of aryl nitrone compounds in methods for treating neuropathic pain |
-
2004
- 2004-06-29 AU AU2004324938A patent/AU2004324938A1/en not_active Abandoned
- 2004-06-29 KR KR1020077001590A patent/KR20070034070A/ko not_active Application Discontinuation
- 2004-06-29 CA CA002572302A patent/CA2572302A1/en not_active Abandoned
- 2004-06-29 JP JP2007518448A patent/JP2008504306A/ja active Pending
- 2004-06-29 EA EA200700102A patent/EA200700102A1/ru unknown
- 2004-06-29 CN CNA200480043472XA patent/CN1976700A/zh active Pending
- 2004-06-29 EP EP04738957A patent/EP1761263A1/en not_active Withdrawn
- 2004-06-29 BR BRPI0418932-9A patent/BRPI0418932A/pt not_active IP Right Cessation
- 2004-06-29 MX MXPA06015196A patent/MXPA06015196A/es not_active Application Discontinuation
- 2004-06-29 WO PCT/DK2004/000460 patent/WO2006053556A1/en active Application Filing
- 2004-12-22 US US11/020,630 patent/US20050288371A1/en not_active Abandoned
-
2006
- 2006-12-21 IL IL180250A patent/IL180250A0/en unknown
-
2007
- 2007-01-25 NO NO20070440A patent/NO20070440L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL180250A0 (en) | 2007-07-04 |
BRPI0418932A (pt) | 2007-11-27 |
CA2572302A1 (en) | 2006-05-26 |
KR20070034070A (ko) | 2007-03-27 |
AU2004324938A1 (en) | 2006-05-26 |
EP1761263A1 (en) | 2007-03-14 |
US20050288371A1 (en) | 2005-12-29 |
JP2008504306A (ja) | 2008-02-14 |
NO20070440L (no) | 2007-01-25 |
MXPA06015196A (es) | 2007-03-15 |
WO2006053556A1 (en) | 2006-05-26 |
CN1976700A (zh) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118472T1 (el) | Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων | |
EP2666472A3 (en) | Uses and compositions for treatment of psoriatic arthritis | |
NO20076413L (no) | Multisykliske forbindelser og fremgangsmater for deres anvendelse | |
CY1113640T1 (el) | Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας | |
EA201001322A1 (ru) | Вакцины против хламидиоза | |
EA201390609A1 (ru) | ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ | |
TN2009000291A1 (en) | Inhibitors of mek | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
NO20092609L (no) | Tannate salt of rasagiline | |
EA201001847A1 (ru) | Соединения и композиции, применяемые для лечения малярии | |
EA201000424A1 (ru) | Антитела к il-23 | |
UA94221C2 (en) | Lipocalin protein | |
NO20070440L (no) | Behandling av nevropatisk smerte, fibromyalgi eller revmatoid artritt | |
EA200701820A1 (ru) | Применение диосметиновых соединений при лечении и профилактике тромботических патологий | |
ATE472998T1 (de) | Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis | |
TW200630367A (en) | Substituted adenines and the uses thereof | |
MA32349B1 (fr) | Antagonistes de la voie hedgehog a base de phtalazines disubstituees | |
MX2009011346A (es) | Tapentadol para tratamiento de dolor con artritis. | |
UA85471C2 (ru) | Применение оксикодона для лечения висцеральной боли | |
EA200870515A1 (ru) | Моноциклические гетероарильные соединения | |
NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
EA200970126A1 (ru) | Способ получения прегабалина и его энантиомера | |
CL2007002387A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de artritis y dolor. | |
NO20060535L (no) | Aztreonam-L-lysin og fremgangsmater for fremstilling av dette | |
EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения |